MondegarAI
SUVRETTA CAPITAL MANAGEMENT, LLC

Q1 2026 · 13F-HR

SUVRETTA CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2026-05-15 · accession 0001172661-26-002340

$3.92B
Reported value
89
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · SUVRETTA CAPITAL MANAGEMENT, LLC · Q1 2026

AI · grounded in 13F

SUVRETTA CAPITAL MANAGEMENT, LLC exited its position in ARKG, reducing its holdings by $241.7M. The fund established a new position in MANE valued at $263.3M and added VMC with a $49.4M investment. Other notable moves include closing positions in KO, HIMS, and NOW, while increasing its stake in CAPR by 113.85%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
03969K108ARQTARCUTIS BIOTHERAPEUTICS INC$290.4M7.42%12,327,000CommonSOLE
922967104MANEVERADERMICS INC$263.3M6.72%4,168,970CommonSOLE
78462F103SPYSTATE STR SPDR S&P 500 ETF T$227.6M5.81%350,000PUTSOLE
697947109PVLAPALVELLA THERAPEUTICS INC NE$143.8M3.67%1,153,496CommonSOLE
03753U106APLSUSDAPELLIS PHARMACEUTICALS INC$141.5M3.62%3,518,471CommonSOLE
52490G102LEGNLEGEND BIOTECH CORP$137.1M3.50%7,581,029CommonSOLE
08205P209BNTCBENITEC BIOPHARMA INC$123.0M3.14%11,548,351CommonSOLE
14070B309CAPRCAPRICOR THERAPEUTICS INC$116.1M2.97%3,818,600CommonSOLE
N44445109IMTXIMMATICS N.V$110.1M2.81%11,190,129CommonSOLE
03969F109RCUSARCUS BIOSCIENCES INC$108.7M2.78%5,030,993CommonSOLE
30233G209EYPTEYEPOINT INC$106.9M2.73%8,296,375CommonSOLE
04272N102AVBPARRIVENT BIOPHARMA INC$101.5M2.59%4,401,083CommonSOLE
874039100TSMTAIWAN SEMICONDUCTOR MANUFAC$100.9M2.58%298,707CommonSOLE
67066G104NVDANVIDIA CORPORATION$100.2M2.56%574,656CommonSOLE
30303M102METAMETA PLATFORMS INC$97.1M2.48%169,707CommonSOLE
483497103KALVKALVISTA PHARMACEUTICALS INC$96.0M2.45%4,768,712CommonSOLE
369604301GEGE AEROSPACE$88.0M2.25%310,262CommonSOLE
G1110E107BHVNBIOHAVEN LTD$87.0M2.22%10,286,937CommonSOLE
871829107SYYSYSCO CORP$82.7M2.11%1,159,156CommonSOLE
552953101MGMMGM RESORTS INTERNATIONAL$79.9M2.04%2,158,800CommonSOLE
20454B104CMPXCOMPASS THERAPEUTICS INC$75.7M1.93%14,307,379CommonSOLE
437076102HDHOME DEPOT INC$72.9M1.86%221,590CommonSOLE
50127T109KURAKURA ONCOLOGY INC$69.7M1.78%8,575,422CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$69.5M1.78%4,226,809CommonSOLE
060505104BACBANK AMERICA CORP$63.1M1.61%1,295,245CommonSOLE
29479A108ERASERASCA INC$55.6M1.42%3,434,967CommonSOLE
14040H105COFCAPITAL ONE FINL CORP$55.2M1.41%302,400CommonSOLE
G9TY5A101ZURAZURA BIO LTD$53.9M1.38%9,067,001CommonSOLE
023135106AMZNAMAZON COM INC$52.9M1.35%254,009CommonSOLE
007903107AMDADVANCED MICRO DEVICES INC$52.3M1.34%257,240CommonSOLE
359616109FULCFULCRUM THERAPEUTICS INC$50.3M1.29%6,561,111CommonSOLE
929160109VMCVULCAN MATLS CO$49.4M1.26%181,594CommonSOLE
31488V107FERGFERGUSON ENTERPRISES INC$49.4M1.26%211,900CommonSOLE
03769M106APOAPOLLO GLOBAL MGMT INC$43.2M1.10%387,700CommonSOLE
603170101MLYSMINERALYS THERAPEUTICS INC$41.7M1.06%1,538,662CommonSOLE
22663K107CRNXCRINETICS PHARMACEUTICALS IN$37.9M0.97%1,043,879CommonSOLE
21217B100CTNMCONTINEUM THERAPEUTICS INC$37.1M0.95%2,841,334CommonSOLE
912008109USFDUS FOODS HLDG CORP$36.5M0.93%395,970CommonSOLE
71377A103PFGCPERFORMANCE FOOD GROUP CO$33.1M0.85%386,885CommonSOLE
76029N106REPLREPLIMUNE GROUP INC$32.3M0.82%4,221,836CommonSOLE
00768Y453MSOSADVISORSHARES TR$32.1M0.82%9,046,200CommonSOLE
05153U107AURAAURA BIOSCIENCES INC$29.3M0.75%4,372,884CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$27.2M0.70%100,630CommonSOLE
74291D104PROKPROKIDNEY CORP$22.1M0.56%12,341,266CommonSOLE
53190C102LTHLIFE TIME GROUP HOLDINGS INC$13.7M0.35%510,349CommonSOLE
00032Q104WHWKWHITEHAWK THERAPEUTICS INC$12.8M0.33%3,700,000CommonSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$12.0M0.31%2,676,000CommonSOLE
974155103WINGWINGSTOP INC$9.2M0.24%59,500CommonSOLE
60853G106MOLNMOLECULAR PARTNERS AG$8.8M0.23%2,221,494CommonSOLE
101137107BSXBOSTON SCIENTIFIC CORP$7.8M0.20%123,941CommonSOLE
52886X107LXEOLEXEO THERAPEUTICS INC$7.2M0.18%1,250,000CommonSOLE
19247G107COHRCOHERENT CORP$7.1M0.18%30,000CommonSOLE
N44821101IFRXINFLARX NV$7.1M0.18%7,933,910CommonSOLE
235851102DHRDANAHER CORP DEL$6.9M0.18%36,380CommonSOLE
002824100ABTABBOTT LABORATORIES$6.9M0.18%66,920CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$6.6M0.17%13,400CommonSOLE
G5960L103MDTMEDTRONIC PLC$6.3M0.16%72,260CommonSOLE
478160104JNJJOHNSON & JOHNSON$5.7M0.15%23,400CommonSOLE
49372L2092KZ0KEZAR LIFE SCIENCES INC$5.3M0.14%716,759CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$5.2M0.13%11,300CommonSOLE
03675P102AVRANTERIS TECHNOLOGIES GLOBAL$4.7M0.12%850,000CommonSOLE
03073E105CORCENCORA INC$3.9M0.10%12,488CommonSOLE
80401L803MSLESATELLOS BIOSCIENCE INC$2.7M0.07%475,000CommonSOLE
592688105MTDMETTLER TOLEDO INTERNATIONAL$2.5M0.06%1,964CommonSOLE
632307104NTRANATERA INC$2.0M0.05%10,100CommonSOLE
252131107DXCMDEXCOM INC$2.0M0.05%31,680CommonSOLE
863667101SYKSTRYKER CORPORATION$1.9M0.05%5,860CommonSOLE
88160R101TSLATESLA INC$1.9M0.05%5,177CommonSOLE
87422Q109TLNTALEN ENERGY CORP$1.9M0.05%5,970CommonSOLE
58507V107MDLNMEDLINE INC$1.9M0.05%42,500CommonSOLE
594918104MSFTMICROSOFT CORP$1.8M0.05%4,970CommonSOLE
58155Q103MCKMCKESSON CORP$1.6M0.04%1,830CommonSOLE
40412C101HCAHCA HEALTHCARE INC$1.5M0.04%3,190CommonSOLE
28176E108EWEDWARDS LIFESCIENCES CORP$1.5M0.04%18,700CommonSOLE
46266C105IQVIQVIA HLDGS INC$1.2M0.03%7,175CommonSOLE
384802104GWWWW GRAINGER INC$1.1M0.03%1,000CommonSOLE
81728A207SNSESENSEI BIOTHERAPEUTICS INC$1.1M0.03%34,549CommonSOLE
941848103WATWATERS CORP$960,4050.02%3,225CommonSOLE
92840M102VSTVISTRA CORP$901,9800.02%6,000CommonSOLE
462222100IONSIONIS PHARMACEUTICALS INC$810,9720.02%10,800CommonSOLE
00846U101AAGILENT TECHNOLOGIES INC$568,7600.01%4,990CommonSOLE
761152107RMDRESMED INC$536,5070.01%2,390CommonSOLE
L8681T102SPOTSPOTIFY TECHNOLOGY S A$533,4010.01%1,100CommonSOLE
92338C103VLTOVERALTO CORP$484,1000.01%5,475CommonSOLE
771049103RBLXROBLOX CORP$476,2350.01%8,420CommonSOLE
803607100SRPTSAREPTA THERAPEUTICS INC$389,2430.01%17,888CommonSOLE
G8473T100STESTERIS PLC$338,3290.01%1,530CommonSOLE
92790C104VRDNVIRIDIAN THERAPEUTICS INC$326,6520.01%16,700CommonSOLE
98956P102ZBHZIMMER BIOMET HOLDINGS INC$294,7690.01%3,260CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.